NASDAQ:VVOS | Profit Breakdown | Vivos Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$5.15M$2.95M-$4.83M-$5.52M-$5.48M
2026-03-31$5.14M$3.06M-$6.62M-$7.75M-$7.68M
2025-12-31$3.82M$2.99M-$6.38M-$6.95M-$6.89M
2025-09-30$6.78M$3.94M-$4.73M-$5.4M-$5.4M
2025-06-30$3.82M$2.11M-$4.87M-$5.01M-$5.01M
2025-03-31$3.02M$1.51M-$3.92M-$3.86M-$3.86M
2024-12-31$3.7M$2.1M-$2.81M-$2.83M-$2.83M
2024-09-30$3.86M$2.33M-$2.65M-$2.62M-$2.62M
2024-06-30$4.05M$2.65M-$1.94M-$1.93M-$1.93M
2024-03-31$3.42M$1.94M-$3.79M-$3.76M-$3.76M
2023-12-31$3.25M$2.09M-$4.13M-$4.26M-$4.26M
2023-09-30$3.3M$1.75M-$3.64M-$2.09M-$2.09M
2023-06-30$3.4M$2.1M-$4.52M-$5.53M-$5.53M
2023-03-31$3.86M$2.34M-$5.01M-$1.7M-$1.7M
2022-12-31$3.95M$2.38M-$6.06M-$6.09M-$6.09M
2022-09-30$4.25M$2.5M-$5.41M-$5.43M-$5.43M
2022-06-30$4.18M$2.59M-$6.96M-$6.99M-$6.99M
2022-03-31$3.64M$2.55M-$6.64M-$5.52M-$5.33M
2021-12-31$4.39M$3.11M-$7.41M-$7.39M-$7.39M
2021-09-30$4.55M$3.18M-$5.5M-$5.45M-$5.45M
2021-06-30$4.5M$3.62M-$4.06M-$4.04M-$4.04M
2021-03-31$3.45M$2.69M-$3.41M-$3.4M-$3.4M
2020-12-31$3.31M$2.69M-$6.25M-$6.25M
2020-09-30$3.29M$2.58M-$1.82M-$1.81M
2020-06-30$3.27M$2.73M-$1.42M-$1.41M
2020-03-31$3.2M$2.42M-$2.56M-$2.58M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$17.44M$10.54M-$19.89M-$21.23M-$21.17M
2024-12-31$15.03M$9.02M-$11.17M-$11.14M-$11.14M
2023-12-31$13.8M$8.27M-$17.3M-$13.58M-$13.58M
2022-12-31$16.02M$10.02M-$25.03M-$23.85M-$23.85M
2021-12-31$16.89M$12.6M-$20.38M-$20.29M-$20.29M
2020-12-31$13.07M$10.41M-$12.04M-$12.06M-$12.06M
2019-12-31$11.39M$8.66M-$10.58M-$10.75M-$10.75M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.